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Abstract―Nanoparticles of antiferromagnetically ordered materials acquire the uncompensated 
magnetic moment caused by defects and surface effects. A bright example of such a nano-
antiferromagnet is nanoferrihydrite consisting of particles 2−5 nm in size, the magnetic moment 
of which amounts to hundreds of Bohr magnetons per particle. We present a brief review of the 
studies on magnetic properties of ferrihydrite produced by bacteria. Special attention is focused 
on the aspects of possible biomedical applications of this material, i.e., the particle elimination, 
toxicity, and possible use for targeted drug delivery. 
 
 
1. Introduction 
 
The materials containing magnetic nanoparticles are interesting both for fundamental 
research concerning the drastic difference of their magnetic properties from those of bulk 
analogs and for application in various fields [1, 2]. It is well-known that as the size of ferro- and 
ferrimagnetic particles decreases, surface atoms start playing a decisive role in the magnetic state 
formation. This often leads to a decrease in the saturation magnetization of a nanostructured 
material due to the break of chemical bonds and spin-glass state of surface atoms [3]. As a result, 
magnetic moment P of ferro- and ferrimagnetic nanoparticles decreases with particle size d 
much faster than the quantity proportional to particle volume V (V ~ d3) [3−5].  
In the antiferromagnetically (AFM) ordered nanoparticles, the surface effects and defects 
in the bulk of particles play a fundamentally different role: these particles acquire 
uncompensated magnetic moment unc, (P = unc), the value of which depends on the particle 
size and defect type. Based on the statistical considerations, Neel proposed the interrelation 
between number of atoms N in a particle (obviously, N ~ V), uncompensated magnetic moment 
unc, and defect type [6] 
unc ~ at N b.    (1) 
Here, at is the magnetic moment of a magnetically active atom and b is the exponent that takes 
the values of 1/3, 1/2, or 2/3 for defects on the surface and in the bulk of a particle or the odd 
number of ferromagnetically ordered planes in a particle. Indeed, according to the data reported 
in [2, 7−15], equality (1) is valid for AFM nanoparticles of different compositions. This gives 
grounds for studying the fundamental properties of AFM nanoparticles and opens the 
opportunities for their application, e.g., in medicine, due to the fact that an AFM particle of a few 
nanometers in size can have a magnetic moment comparable with that of a ferro- or 
ferrimagnetic particle.  
  
Ferrihydrite with the nominal chemical formula 5Fe2O3 · 9H2O (the number of OH bonds 
and water content can change under the action of structural defects) stands out from the diversity 
of AFM-ordered nanoparticle types. This mineral exists in the nanosized form in almost all 
living organisms and works as an iron repository, being a part of the so-called ferritin. Ferritin 
extracted from a horse spleen was thoroughly investigated [7, 10, 14, 15]. It was established that 
the unc value for ferritin with a ferrihydrite core ~ 5 nm in size amounts to several Bohr 
magnetons (B).  
Ferrihydrite nanoparticles can be obtained using chemical methods [16, 17] or by 
extracting the products of bacteria vital activity. One of the techniques for preparing bacterial 
ferrihydrite is based on cultivation of Klebsiella oxytoca bacteria from lake bottom sediments 
[18, 19]. This study presents a brief review of the investigations of the magnetic properties of 
bacterial ferrihydrite nanoparticles, the possibility of targeted particle coarsening by heat 
treatment [20, 21] and, as a consequence, modification of the magnetic properties of this 
material, and the results of the clinical examination of laboratory animals with the use of 
ferrihydrite nanoparticles.  
 
2. Preparation and characterization of biogenic ferrihydrite nanoparticles 
The Klebsiella oxytoca strain used for producing ferrihydrite was extracted from the 
sapropel of the Borovoe lake, Krasnoyarsk territory. Microorganisms were inoculated into an 
agar medium and grown under anaerobic conditions. After multiple ultrasonic processing of 
bacterial sediments, centrifugation, and washing, a stable sol of nanoparticles in an aqueous 
solution was fabricated and dried. The obtained powder of magnetic nanoparticles is hereinafter 
referred to as as-prepared sample. Note that as-prepared samples of different sets demonstrated 
similar characteristics. A part of the powder was kept in air at temperatures within the range of 
150−2000C for different times. 
X-ray diffraction patterns of the prepared samples are characteristic of the amorphous 
state. The ferrihydrite nanoparticles were characterized by Mössbauer spectroscopy. According 
to the Mössbauer spectra, iron atoms in bacterial ferrihydrite can occupy three sites with 
different quadrupole splittings characteristic of ferrihydrite [18, 20, 22]. The results of analysis 
of Mössbauer spectra are mainly identical for as-prepared samples of different sets. The 
formation of new iron oxide phases in bacterial ferrihydrite upon annealing was not observed 
[13, 20].  
Typical transmission electron microscopy (TEM) data for the as-prepared ferrihydrite 
sample are shown in the Fig.1. The average ferrihydrite nanoparticle size <d> estimated from 
several micrographs was found to be ~ 2.7 nm. The low-temperature heat treatment leads to the 
increase in the particle size (the <d> value of the sample treated at 1500C for 24 h is ~ 4 nm). 
 Fig.1. Typical TEM micrographs obtained using a Hitachi HТ7700 facility. 
 
3. Magnetic properties of bacterial ferrihydrite nanoparticles and their transformation 
upon low-temperature heat treatment  
3.1. Superparamagnetic behavior of bacterial ferrihydrite nanaoparticles, the origin of 
uncompensated magnetic moment and the effect of low temperature heat annealing. 
Figure 2 presents typical temperature dependences of the magnetic moment M(T) obtained 
upon cooling the ferrihydrite samples annealed for different times at temperatures of   150 and 
2000C in the nonzero (FC) and nonzero (ZFC) external field modes. The difference between the 
M(T)ZFC and M(T)FC dependences and the pronounced maximum in the M(T)ZFC dependences 
evidence for the superparamagnetic (SP) behavior of the investigated particles. In addition, 
according to our data, the maximum temperature (hereinafter, blocking temperature TB) shifts 
toward lower temperatures, which is typical of the SP systems. Note that for the as-prepared 
ferrihydrite samples from different series the TB value in the same field differed by no more than 
3 deg and lied between 23−25K (H = 1 kOe). In addition, it can be seen in Fig. 2 that annealing 
significantly increases the blocking temperature and this effect is governed by the annealing 
temperature and time.  
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Fig. 2. FC and ZFC M(T) dependences for the as-prepared and annealed ferrihydrite samples. 
 
FH (as-prepared) FH (annealed for 24 h) 
Based on the classical Néel–Brown relation 
kTB = KeffV / ln(/0)  ≈ KeffV/ 25,   (2) 
where k is the Boltzmann constant, Keff is the effective magnetic anisotropy constant; V is the 
particle volume;  and 0 ~ 10−9−10−10 s are the characteristic times of the measurements 
( ~ 102 s for the magnetic measurements) and particle relaxation, we may conclude that the 
annealing increases the particle size. This is confirmed by the TEM data (Fig. 1).  
The particle size growth during annealing is confirmed also by the magnetization curves 
M(H) in the temperature range of T > TB. Figure 3 shows magnetization isotherms for the as-
prepared samples and the samples annealed at 1600С for 24 h. According to the generally 
accepted approach, the magnetization curve of the ensemble of AFM nanoparticles in the region 
of T > TB can be described by the expression 
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Fig. 3. Experimental (dots) and fitting (lines, expression (3)) M(H) dependences for the 
ferrihydrite samples. The inset on the left shows the temperature behavior of fitting parameter 
<P>.  
 
This expression was written with regard to the distribution over magnetic moments f(P). The 
first term of (3) describes the alignment of particle magnetic moments P along the external field 
direction in accordance with the classical Langevin function L(P, H) 
(L(P, H) = coth(P×H / kT) - 1/(P×H/kT); NP is the number of particles in unit mass. The 
second term AFH describes the cant of sublattices of the AFM particle core (AF is the AFM 
susceptibility of the particle core). Solid lines in Fig. 3 show the best fitting of the experimental 
data by expression (3) using the lognormal distribution over the magnetic moments: 
f(P) = (Ps(2)1/2)-1 exp{-[ln(P/n)]2/2s2}, where <P> = nexp(s2) is the average particle 
magnetic moment and s2 is the ln(P) dispersion.  
The inset in Fig. 3b illustrates the temperature behavior of <P>, which is described well by 
the law <P(T)> = <P(T = 0)>  (1 – Ta) at typical a values between 1.5−2.0. It can be seen that 
annealing leads to a noticeable increase in <P>. This allows us to reliably determine the <P> 
value from the M(H) data at T = 0 for the as-prepared and annealed samples (162 B and 302 B, 
respectively). These values correspond to the numbers of uncompensated iron atoms of ~30 and 
~60 (at Fe3+ = 5B) and agree well with the model Neel hypothesis with the exponent b ≈ ½ in 
Eq. (1). Indeed, using the values of <d> ≈ 2.7 nm for the as-prepared sample and ~4.0 nm for the 
annealed sample (Fig. 1 shows the data for this sample series) and taking an average distance of 
0.31 nm between Fe atoms in ferrihydrite [9], we obtain the numbers of iron atoms of N ~ 600 
and 2200 in the approximation of the cubic particle shape and, consequently, N1/2 ≈ 25 and ≈ 47. 
Thus, the uncompensated magnetic moment of the bacterial ferrihydrite occurs due to defects 
both on the surface and in the bulk of a sample. 
The dependence of the quantity <P(T = 0)> on annealing time is illustrated in Fig. 4. It 
seems reasonable to explain the particle coarsening upon annealing by the agglomeration of 
neighboring particles [20, 21]: note that at higher temperatures, ferrihydrite decomposes with the 
formation of the hematite phase [22]. One may conclude that low-temperature annealing on air is 
the effective way to change the size as well as magnetic properties (the blocking temperature, the 
value of uncompensated magnetic moment) of ferrihydrite nanoparticles. 
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Fig. 4. Average magnetic moment <P(T = 0)>  of ferrihydrite particles (left scale) and 
coercivity HC (at T = 4.2 K and Hmax = 60kOe, ) vs time of annealing at 160
0С.  
 
3.2.  
Within the temperature range T < TB the isotherms of magnetization M(H) are hysteretic. 
At T = 4.2 K the value of coercivity HC (obtained from M(H) curves measured at the maximal 
applied field Hmax =  60 kOe) lies within 1.5-3.0 kOe for as prepared samples from different 
series. Low-temperature annealing leads (besides increase in size, TB and <P> values, see 
Sec.3.1) to enhancement of coercivity at T = 4.2 K. The Fig.4 shows this behavior. This is in 
accordance with Stoner-Wohlfarth expression for single domain particles: HC ≈  
M
K
S
eff
[1– 
(T / TB)
1/2], where MS – is the saturation magnetization. Indeed, MS = P / V and P ~ N1/2 ~ V1/2. 
Therefore, MS ~ V
-1/2 and HC ~ V
1/2, i.e., coercivity increases with growth of particle size. 
From the other hand, AF nanoparticles are known to exhibit very high irreversibility field 
[]. Therefore, in the most cases the M(H) hysteretic dependences are partial []. Also, many 
authors observed a shift of hysteresis loop on systems of AF nanoparticles after cooling in a 
magnetic field from a temperature which is higher than the blocking temperature [] (FC 
conditions). However, it is questionable does the shift of M(H) hysteresis is due to internal effect 
(exchange bias) or this is an analogue of the minor loop effect after field cooling. Here we show 
a method how it is possible to separate these effects. 
An example of ZFC M(H) hysteresis curve obtained by cycling external field up its 
maximal values Hmax with a gradual increase in the Hmax is shown on Fig.5. M(H) curves 
measured after field cooling at H = 30 kOe are also shown in this figure. The Fig.6 shows the HC 
values as a function of maximal applied field Hmax deduced from M(H) data (Fig.5) for both ZFC 
and FC cases. It is seen that HC(Hmax) dependence has a tendency to saturation. Silva [silva] 
argued that this dependence can be described by the following expression: 
HC(Hmax) = HCinf [1 – (H*/Hmax)].   (4) 
Here HCinf – is the “infinite coercivity” (i.e. HC at high Hmax). Expression (3) is valid at the ﬁelds 
higher than H*, and the exponent  is determined by the structure of energy barriers which the 
particle moment P overcomes during magnetization process [silva]. Experimental data HC(Hmax) 
are well described by expression (4) within the range H > 30 kOe at  = &&, H* = &&, and 
HCinf ≈ 3.8 kOe. The magnitude of HCinf is shown on Fig.6 as horizontal dashed line. It is seen 
from the Fig.6 that FC HC values noticeable exceed HCinf. This supports that observed shift of 
M(H) loop after field cooling is due to internal effect.  
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There are at least two possible mechanisms of this behavior. The first mechanism is 
exchange bias which is known to take place in FM/AF (FM – is ferro- or ferrimagnet) structures 
(films) or core/shell nanoparticles []. In the case of “pure” AF nanoparticles there is a possibility 
of exchange coupling between uncompensated magnetic moment P (FM) and AF “core” of a 
particle []. The second mechanism was pointed out by Berkowits and Kodama; they have shown 
that existence of large number of the broken exchange bonds on the surface can lead to the 
occurrence of the multi-sublattice states in an AF nanoparticle and this may result to the shift of 
M(H) loop after field cooling. The Fig.7 shows the dependence HEB as a function of particle size 
d obtained on ferrihydrite samples undergone heat treatment for different times. The loop shift is 
not observed for ferrihydrite nanoparticles whose size is less than 3 nm. Increase of HEB values 
with size is seen from the Fig.7. Similar behavior was observed on CuO and NiO 
nanoparticles…..  
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4. Possible applications in medicine 
4.1.  Elimination of ferrihydrite nanoparticles from the organism 
Elimination of ferrihydrite nanoparticles from the organism was studied by NMR 
tomography on laboratory animals (mice). The suspension containing 0.7 g/l H2O was injected 
singly abdominally in amount of 1 ml or singly intramuscularly in a thigh in amount of 0.1 ml.  
The tomography study was carried out on a Bruker Avance DPX 200 NMR facility in a field 
of 4.7 T with a Greate 3/60 gradient block. The 1H nuclear tomographic images were obtained by 
a spin-echo technique [23]. 
Figure 5 shows typical tomographic images of the thigh cross section in 15 min and 2 h after 
the intramuscular injection of the suspension. For a time period of 15 min, the signal intensity 
noticeably increases (shown by the arrow in Fig. 5a), which is reasonable to attribute to the 
presence of magnetic nanoparticles. However, for a period of 2 h, we noticed no changes in the 
signal intensity within the sensitivity of the method (10 µg per 1 g of tissue). These results were 
obtained also for the cross-sectional peritoneal cavity images after the abdominal drug injection. 
Based on the results obtained, we may conclude that ferrihydrite nanoparticles can be eliminated, 
at least, at the intramuscular and abdominal injection.  
 Fig. 5. Tomography images of the thigh cross section in 15 min and 2 h after the 
intramuscular injection of the suspension of ferrihydrite nanoparticles. 
 
4.2. Targeted drug delivery and nontoxicity of ferrihydrite NPs 
To establish the possibility of targeted drug delivery and effect of magnetic nanoparticles on 
the conditions of inflammatory and reparative processes of laboratory animals, we compared the 
results of treatment of three groups of animals (rats). The animals of group I were not treated, the 
animals of group II were treated by ampicillin, and the animals of group III were treated by 
ampicillin (500 mg) combined with ferrihydrite nanoparticles. The thermal injury region was 
affected by an external magnetic field (Polyus-101, magnetic field gradient of 4−6 mT/mm, and 
magnetic induction of 10−20 mT) for 20 min.  
Macroscopic control of the reparative process of burnt rats showed that in the group of 
animals treated locally by ampicillin with nanoparticles, the wound healing occurred twofold 
faster than in the group of animals treated by pure  ampicillin (Fig. 6). 
 
 
Fig 6. Thermal injury of rats treated by (a) ampicillin and (b) ampicillin with magnetic 
nanoparticles in seven days. 
 
The cytological examination of thermal injury smears showed that during the first day after the 
burn all animals experienced the degenerative inflammatory changes. The local use of ampicillin 
with nanoparticles in group III significantly reduced the inflammation and activated the tissue 
regeneration, which was reflected in the regenerative inflammatory cytogram type.  
Comparative analysis of the microflora of the rats treated by ampicillin showed that the 
Staphylococcus bacteria on the thermal injury surface retained their content [25]. The situation 
was opposite in the group of rats treated by ampicillin with magnetic nanoparticles. The amount 
of Staphylococcus bacteria was much smaller. 
 
5. Conclusions 
The nanoparticles of biogenic ferrihydrite obtained from the Klebsiella oxytoca bacteria vital 
products have the uncompensated magnetic moment caused by defects on the surface and in the 
bulk of the particles. The presence of a magnetic moment of particles leads to the characteristic 
SP behavior. The described procedure yields nanoparticles ~ 3 nm in size with an SP blocking 
temperature of ~23−25 K, and an average particle magnetic moment of 150−200 µB. Heat 
treatment at 150−2000С increases the TB and <µP> values due to the particle coarsening via 
agglomeration. Note that the particles over 3 nm in size (or with the TB value higher than 40 K) 
exhibit the exchange bias effect, i.e., the magnetic hysteresis loop shift after cooling in an 
external magnetic field starting from the temperature higher than TB [26].  
According to the NMR study, elimination of ferrihydrite nanoparticles at the intermuscular 
and abdominal injection occurs for the time of no longer than 2 h. The positive results of using 
the drugs in combination with nanoparticles for treating thermal injuries under the action of a 
gradient magnetic field together with ferrihydrite nontoxicity open wide opportunities for 
application of these nanoparticles in biomedicine.  
The reported study was funded by Russian Foundation for Basic Research, Government of Krasnoyarsk 
Territory, Krasnoyarsk Region Science and Technology Support Fund to the research projects № 17-42-
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